Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Cytarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 33 Burkitt Lymphoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Biphenotypic, Acute 7 Myelodysplastic Syndromes 5 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Recurrence 3 Myeloproliferative Disorders 3 Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Hematologic Neoplasms 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Myeloid 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Myasthenia Gravis 1 Medulloblastoma 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1

Interventions

Cyclophosphamide 12 Rituximab 11 obinutuzumab 9 fludarabine 9 Prednisone 7 ibrutinib 6 Lenalidomide 6 tocilizumab 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 Doxorubicin 4 polatuzumab vedotin 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡